Over 65

People over 65 have a much worse outlook than people of working age because they are often not fit enough to have intensive treatment. Before chemotherapy treatment median survival from diagnosis was about 7 months. Median survival with chemotherapy treatment varies from 29-62 months, depending on stage. The overall outlook of everyone with myeloma including the young people who do better is a 1 year survival rate of 55% and a 10 year survival rate of 3%-12%.

Amended February 2009